Fort Lauderdale Agreement

Fort Lauderdale Agreement The Fort Lauderdale Agreement is a 2003 accord on prepublication genomic data sharing reached at a meeting in Fort Lauderdale, Florida, involving representatives from the Wellcome Trust, the National Institutes of Health, the Wellcome Trust Sanger Institute, and the European Bioinformatics Institute. It established policies for rapid release of large-scale sequencing data to public repositories such as the European Molecular Biology Laboratory's European Nucleotide Archive, the DNA Data Bank of Japan, and the GenBank division of the National Center for Biotechnology Information, influencing projects like the Human Genome Project and the International HapMap Project. The Agreement addressed expectations for investigators from organizations including the Howard Hughes Medical Institute, the Francis Crick Institute, and the Broad Institute of MIT and Harvard, aiming to balance the interests of sequencing consortia, funding bodies, and downstream users including groups such as the Wellcome Trust Case Control Consortium, the 1000 Genomes Project, and the ENCODE Project.

Background and Origins

The meeting that produced the Agreement was convened against the backdrop of initiatives such as the Human Genome Project, the Sanger Centre's large-scale sequencing activities, and emerging efforts like the International Human Genome Sequencing Consortium and the Celera Genomics competition. Key participants included representatives from the Wellcome Trust Sanger Institute, the European Bioinformatics Institute, the National Institutes of Health, and major sequencing centers such as the Washington University School of Medicine and the Broad Institute, alongside funders like the Wellcome Trust and policy bodies such as the World Health Organization. Debates echoing earlier disputes involving the Human Genome Project and the Bermuda Principles informed the meeting, while contemporaneous projects including the HapMap Project and the Sanger Centre's pathogen sequencing programs highlighted tensions over data release, intellectual property claims, and publication priority among centers like the Broad Institute, the Sanger Institute, and commercial entities such as Celera Genomics.

Key Principles and Provisions

The Agreement articulated principles for rapid prepublication release of sequence data to public archives such as the European Nucleotide Archive, GenBank, and the DNA Data Bank of Japan, and recommended metadata standards compatible with resources like the UniProt consortium, the Gene Ontology project, and databases maintained by the European Bioinformatics Institute. It encouraged sequencing centers and consortia—examples include the International HapMap Project, the 1000 Genomes Project, and the Human Microbiome Project—to adopt data release policies that allowed downstream researchers from institutions like the Wellcome Trust Sanger Institute, the Broad Institute, and the National Institutes of Health to analyze data while recognizing the sequencing groups’ rights to publish primary analyses. The text recommended community norms addressing attribution, collaboration frameworks used by groups such as the ENCODE Project and the Cancer Genome Atlas, and interoperability with standards from organizations including the Global Alliance for Genomics and Health and the Open Biological Ontologies community.

Implementation and Impact on Research Communities

Implementation of the Agreement influenced repositories including GenBank, the European Nucleotide Archive, and the DNA Data Bank of Japan, and shaped policies at funders such as the Wellcome Trust, the National Institutes of Health, and the Wellcome Trust Sanger Institute. Large-scale initiatives like the 1000 Genomes Project, the Human Microbiome Project, the ENCODE Project, and the Cancer Genome Atlas adopted rapid-release practices consistent with the Agreement, affecting research groups at institutions such as the Broad Institute, the European Bioinformatics Institute, and the Sanger Institute. The practices promoted interoperability with resources like UniProt, the Gene Ontology consortium, and the Protein Data Bank, and informed infrastructure development at archives run by the National Center for Biotechnology Information and the European Bioinformatics Institute, facilitating secondary analysis by consortia such as the International Cancer Genome Consortium and the International HapMap Project.

Controversies and Criticisms

Critics from entities including commercial developers like Celera Genomics, academic investigators at the Broad Institute and the Wellcome Trust Sanger Institute, and policy commentators associated with the World Health Organization raised concerns about priority, attribution, and downstream commercialization rights when data were released prepublication. Debates referenced earlier policy disputes involving the Bermuda Principles and raised issues relevant to legal frameworks such as national intellectual property regimes and cases considered by organizations like the European Patent Office and the United States Patent and Trademark Office. Community groups including patient organizations and research networks such as the Global Alliance for Genomics and Health and the Human Variome Project highlighted privacy, consent, and benefit-sharing tensions that also featured in discussions by the Council for International Organizations of Medical Sciences and the World Health Organization.

Legacy and Influence on Open Data Policy

The Agreement's legacy is visible in policies adopted by funders like the Wellcome Trust, the National Institutes of Health, the European Commission, and the Wellcome Trust Sanger Institute and in norms endorsed by consortia such as the 1000 Genomes Project, the ENCODE Project, and the International Cancer Genome Consortium. Its principles informed later frameworks developed by the Global Alliance for Genomics and Health, standards bodies including the Open Biological and Biomedical Ontology community, and archives such as the European Nucleotide Archive and GenBank. The Agreement helped catalyze open-data movements seen in projects like the Human Genome Project, the Bermuda Principles, and initiatives supported by the Wellcome Trust and the National Institutes of Health, continuing to shape dialogues involving institutions such as the Broad Institute, the European Bioinformatics Institute, and the Sanger Institute about data sharing, attribution, and research utility.

Category:Genomics Category:Open data policy